Study of Synthesis of 3'-Deoxy-3'-[18F]fluorothymidine – Prospective Radiopharmaceutical in Positron Emission Tomography

Authors

  • L. Procházka Nuclear Physics Institute, Academy of Sciences of the Czech Republic, Řež near Prague
  • M. Kropáček Nuclear Physics Institute, Academy of Sciences of the Czech Republic, Řež near Prague
  • M. Mirzajevová Nuclear Physics Institute, Academy of Sciences of the Czech Republic, Řež near Prague
  • J. Zimová Nuclear Physics Institute, Academy of Sciences of the Czech Republic, Řež near Prague
  • M. Försterová Nuclear Physics Institute, Academy of Sciences of the Czech Republic, Řež near Prague
  • H. Švecová Nuclear Physics Institute, Academy of Sciences of the Czech Republic, Řež near Prague
  • F. Melichar Nuclear Physics Institute, Academy of Sciences of the Czech Republic, Řež near Prague

Abstract

18F-Labelled compounds as active substances of radiopharmaceuticals are used for imaging in positron emission tomography (PET) in nuclear medicine. The radiosynthesis of PET radiopharmaceuticals is based on nucleophilic substitution with F? in a precursor. The synthesis is demonstrated on 3'-deoxy-3'-[18F]fluorothymidine.

Published

2008-12-15

How to Cite

Procházka, L., Kropáček, M., Mirzajevová, M., Zimová, J., Försterová, M., Švecová, H., & Melichar, F. (2008). Study of Synthesis of 3’-Deoxy-3’-[18F]fluorothymidine – Prospective Radiopharmaceutical in Positron Emission Tomography. Chemické Listy, 102(11). Retrieved from http://ww-w.chemicke-listy.cz/ojs3/index.php/chemicke-listy/article/view/1601

Issue

Section

Articles

Most read articles by the same author(s)